KR101421747B1 - 모르피논의 입체선택적 환원 - Google Patents

모르피논의 입체선택적 환원 Download PDF

Info

Publication number
KR101421747B1
KR101421747B1 KR1020087028010A KR20087028010A KR101421747B1 KR 101421747 B1 KR101421747 B1 KR 101421747B1 KR 1020087028010 A KR1020087028010 A KR 1020087028010A KR 20087028010 A KR20087028010 A KR 20087028010A KR 101421747 B1 KR101421747 B1 KR 101421747B1
Authority
KR
South Korea
Prior art keywords
morphinone
group
delete delete
daltons
sodium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020087028010A
Other languages
English (en)
Korean (ko)
Other versions
KR20080110910A (ko
Inventor
린 청
마이클 디 벤틀리
Original Assignee
넥타르 테라퓨틱스
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38625648&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=KR101421747(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by 넥타르 테라퓨틱스 filed Critical 넥타르 테라퓨틱스
Publication of KR20080110910A publication Critical patent/KR20080110910A/ko
Application granted granted Critical
Publication of KR101421747B1 publication Critical patent/KR101421747B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/02—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with oxygen atoms attached in positions 3 and 6, e.g. morphine, morphinone
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Catalysts (AREA)
  • Steroid Compounds (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
KR1020087028010A 2006-04-21 2007-04-19 모르피논의 입체선택적 환원 Active KR101421747B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US74533606P 2006-04-21 2006-04-21
US60/745,336 2006-04-21
PCT/US2007/009761 WO2007124114A2 (en) 2006-04-21 2007-04-19 Stereoselective reduction of a morphinone

Publications (2)

Publication Number Publication Date
KR20080110910A KR20080110910A (ko) 2008-12-19
KR101421747B1 true KR101421747B1 (ko) 2014-07-30

Family

ID=38625648

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020087028010A Active KR101421747B1 (ko) 2006-04-21 2007-04-19 모르피논의 입체선택적 환원

Country Status (13)

Country Link
US (2) US8183376B2 (https=)
EP (1) EP2010539B1 (https=)
JP (1) JP5586223B2 (https=)
KR (1) KR101421747B1 (https=)
CN (1) CN101466381B (https=)
AU (1) AU2007240680B2 (https=)
CA (1) CA2646313C (https=)
ES (1) ES2629766T3 (https=)
IL (1) IL194735A (https=)
MX (1) MX2008013594A (https=)
NZ (1) NZ572252A (https=)
WO (1) WO2007124114A2 (https=)
ZA (1) ZA200809258B (https=)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2654819T3 (es) * 2001-10-18 2018-02-15 Nektar Therapeutics Conjugados poliméricos de antagonistas de opioides
EP2905033B1 (en) * 2003-12-16 2020-09-02 Nektar Therapeutics Monodisperse PEGylated naloxol compositions
US20060182692A1 (en) 2003-12-16 2006-08-17 Fishburn C S Chemically modified small molecules
US10512644B2 (en) 2007-03-12 2019-12-24 Inheris Pharmaceuticals, Inc. Oligomer-opioid agonist conjugates
US8173666B2 (en) 2007-03-12 2012-05-08 Nektar Therapeutics Oligomer-opioid agonist conjugates
MX2010011727A (es) * 2008-05-07 2010-11-30 Nektar Therapeutics Administracion oral de antagonistas opioides que actuan perifericamente.
WO2009155259A1 (en) * 2008-06-17 2009-12-23 Mallinckrodt Inc. Processes for the preparation of 6- beta-hydroxy morphinan compounds
KR101660996B1 (ko) * 2008-09-16 2016-09-28 넥타르 테라퓨틱스 남용에 대한 낮은 잠재성을 갖는 페길화 오피오이드
KR20120088537A (ko) 2009-04-24 2012-08-08 브럭 유니버시티 모르피난 및 모르피논 화합물의 제조방법
CA2802295C (en) 2010-06-11 2016-09-20 Rhodes Technologies Transition metal-catalyzed processes for the preparation of n-allyl compounds and use thereof
AU2011263416B2 (en) 2010-06-11 2014-04-10 Rhodes Technologies Process for N-dealkylation of tertiary amines
AU2011307608B8 (en) 2010-09-30 2015-08-27 Grünenthal GmbH Crystalline naloxol-PEG conjugate
CN103289075B (zh) * 2012-02-22 2016-01-20 天津键凯科技有限公司 聚乙二醇与纳洛酮的结合物及其药物组合物和应用
LT2914599T (lt) 2012-10-30 2018-02-12 Nektar Therapeutics Alfa-6-mpeg6-hidroksikodono, kaip opioidų agonistų, kieta druskos forma ir jos panaudojimas
LT3137081T (lt) 2014-04-28 2018-02-26 Orphomed, Inc. Buprenorfino dimeras ir jo naudojimas gydant virškinamojo trakto sutrikimus
WO2016028636A1 (en) * 2014-08-16 2016-02-25 Memorial Sloan Kettering Cancer Center Helical polycarbodiimide polymers and associated imaging, diagnostic, and therapeutic methods
CN107033155B (zh) * 2016-02-04 2019-04-26 国药集团国瑞药业有限公司 一种吗啡酮类化合物的立体选择性还原方法
US11077103B2 (en) * 2016-11-23 2021-08-03 Aurobindo Pharma Ltd. Naloxegol oxalate and solid dispersion thereof
CN110305142B (zh) * 2019-07-12 2021-11-16 宜昌人福药业有限责任公司 一种6β-羟基吗啡衍生物的立体选择性合成方法
CN110330500B (zh) * 2019-07-12 2021-11-23 宜昌人福药业有限责任公司 一种6β-羟基-7,8-二氢-吗啡衍生物的立体选择性合成方法

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992022330A1 (en) 1991-06-14 1992-12-23 The United States Of America, Represented By The Secretary, United States Department Of Commerce RADIOLABELED N-SUBSTITUTED-6-3,14-DIHYDROXY-4,5 αEPOXYMORPHINANS, THEIR INTERMEDIATES, METHODS OF PREPARATION AND USE
WO1995032973A1 (en) * 1994-05-31 1995-12-07 Mallinckrodt Chemical, Inc. The preparation of nalbuphine having low levels of beta-epimer
WO2005058367A2 (en) * 2003-12-16 2005-06-30 Nektar Therapeutics Al, Corporation Pegylated small molecules

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2654756A (en) 1949-10-20 1953-10-06 Mallinckrodt Chemical Works Process of preparing codeinone, dihydrocodeinone, and dihydromorphinone
US2628962A (en) 1949-10-20 1953-02-17 Mallinckrodt Chemical Works Method for preparing dihydrocodeinone, dihydromorphinone, and codeinone
US2715626A (en) 1950-07-05 1955-08-16 Merck & Co Inc Process of preparing dihydrocodeinone
US2649454A (en) 1951-08-20 1953-08-18 Univ California Method for preparing dihydromorphinone, dihydrocodeinone, and dihydropseudocodeinone
US2654746A (en) 1952-02-13 1953-10-06 Lilly Co Eli 1-dimethylamino-4-chloro-4-phenylbutane salt of penicillin
US2806033A (en) 1955-08-03 1957-09-10 Lewenstein Morphine derivative
US3254088A (en) 1961-03-14 1966-05-31 Lewenstein Morphine derivative
US3332950A (en) 1963-03-23 1967-07-25 Endo Lab 14-hydroxydihydronormorphinone derivatives
IL26896A (en) 1966-01-19 1970-11-30 Endo Lab 14 - Hydroxynormorphinins and 14 - Hydroxynormorphinones
DE2538075A1 (de) * 1975-08-27 1977-03-17 Boehringer Sohn Ingelheim N-tetrahydrofurfuryl-noroxymorphone, deren saeureadditionssalze, diese enthaltende arzneimittel sowie verfahren zu ihrer herstellung
US4089855A (en) * 1976-04-23 1978-05-16 Cornell Research Foundation, Inc. Process for the stereoselective reduction of 6- and 8-keto morphine and morphinan derivatives with formamidinesulfinic acid and compounds obtained thereby
GB1593191A (en) * 1977-03-23 1981-07-15 Reckitt & Colmann Prod Ltd Derivatives of morphine
US4451470A (en) * 1982-07-06 1984-05-29 E. I. Du Pont De Nemours And Company Analgesic, antagonist, and/or anorectic 14-fluoromorphinans
DE4132159A1 (de) * 1991-09-27 1993-04-01 Boehringer Ingelheim Kg 14-hydroxy-n-(2-methoxyethyl)-7,8-dihydromorphin und -norisomorphin, verfahren zu deren herstellung und deren verwendung als arzneimittel
KR970011390B1 (ko) * 1992-01-23 1997-07-10 도레이 가부시키가이샤 모르피난 유도체와 약리학적으로 허용되는 이의 산 부가염 및 이를 함유하는 약제학적 조성물
US5428159A (en) 1994-04-08 1995-06-27 Ciba-Geigy Corporation Method of manufacture of (-)-galanthamine in high yield and purity substantially free of epigalanthamine
US5932462A (en) 1995-01-10 1999-08-03 Shearwater Polymers, Inc. Multiarmed, monofunctional, polymer for coupling to molecules and surfaces
US5672662A (en) 1995-07-07 1997-09-30 Shearwater Polymers, Inc. Poly(ethylene glycol) and related polymers monosubstituted with propionic or butanoic acids and functional derivatives thereof for biotechnical applications
ES2654819T3 (es) 2001-10-18 2018-02-15 Nektar Therapeutics Conjugados poliméricos de antagonistas de opioides

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992022330A1 (en) 1991-06-14 1992-12-23 The United States Of America, Represented By The Secretary, United States Department Of Commerce RADIOLABELED N-SUBSTITUTED-6-3,14-DIHYDROXY-4,5 αEPOXYMORPHINANS, THEIR INTERMEDIATES, METHODS OF PREPARATION AND USE
WO1995032973A1 (en) * 1994-05-31 1995-12-07 Mallinckrodt Chemical, Inc. The preparation of nalbuphine having low levels of beta-epimer
WO2005058367A2 (en) * 2003-12-16 2005-06-30 Nektar Therapeutics Al, Corporation Pegylated small molecules

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
J. Med. Chem. 1990, 제33권 제737-741면. *

Also Published As

Publication number Publication date
US8183376B2 (en) 2012-05-22
US8563726B2 (en) 2013-10-22
US20130018190A1 (en) 2013-01-17
US20090221766A1 (en) 2009-09-03
CA2646313C (en) 2014-05-20
EP2010539B1 (en) 2017-06-14
IL194735A0 (en) 2009-08-03
EP2010539A2 (en) 2009-01-07
CN101466381A (zh) 2009-06-24
IL194735A (en) 2015-09-24
NZ572252A (en) 2011-09-30
AU2007240680A1 (en) 2007-11-01
JP5586223B2 (ja) 2014-09-10
ZA200809258B (en) 2010-08-25
EP2010539A4 (en) 2010-06-02
JP2009534393A (ja) 2009-09-24
CA2646313A1 (en) 2007-11-01
AU2007240680B2 (en) 2013-05-02
WO2007124114A3 (en) 2008-11-27
ES2629766T3 (es) 2017-08-14
KR20080110910A (ko) 2008-12-19
MX2008013594A (es) 2009-01-16
HK1134903A1 (en) 2010-05-20
WO2007124114A2 (en) 2007-11-01
CN101466381B (zh) 2012-11-14

Similar Documents

Publication Publication Date Title
KR101421747B1 (ko) 모르피논의 입체선택적 환원
JP5901073B2 (ja) マルチアームポリマー−薬物コンジュゲートの塩形態
KR101009309B1 (ko) 아편양 길항제의 중합체 공액
JP5837491B2 (ja) オリゴマー−オピオイドアゴニスト抱合体
CN101646464A (zh) 低聚物-阿片样激动剂偶联物
US9126926B2 (en) Oligomer-anticholinergic agent conjugates
HK1134903B (en) Stereoselective reduction of a morphinone
HK1173361A (en) Salt form of a multi-arm polymer-drug conjugate
HK1173361B (en) Salt form of a multi-arm polymer-drug conjugate

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20081117

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
N231 Notification of change of applicant
PN2301 Change of applicant

Patent event date: 20100203

Comment text: Notification of Change of Applicant

Patent event code: PN23011R01D

A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20120419

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20130923

Patent event code: PE09021S01D

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 20140429

GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 20140715

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 20140715

End annual number: 3

Start annual number: 1

PG1601 Publication of registration
FPAY Annual fee payment

Payment date: 20170629

Year of fee payment: 4

PR1001 Payment of annual fee

Payment date: 20170629

Start annual number: 4

End annual number: 4

FPAY Annual fee payment

Payment date: 20180628

Year of fee payment: 5

PR1001 Payment of annual fee

Payment date: 20180628

Start annual number: 5

End annual number: 5

PR1001 Payment of annual fee

Payment date: 20200624

Start annual number: 7

End annual number: 7

PR1001 Payment of annual fee

Payment date: 20220622

Start annual number: 9

End annual number: 9

PR1001 Payment of annual fee

Payment date: 20230626

Start annual number: 10

End annual number: 10

PR1001 Payment of annual fee

Payment date: 20240624

Start annual number: 11

End annual number: 11